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ABSTRACT The behavior of mixed bile salt micelles consisting of sodium taurocholate, egg phosphatidylcholine, and cho-
lesterol has been studied by ESR spin labeling and synchrotron x-ray scattering. Consistent with published phase diagrams,
pure and mixed bile salt micelles have a limited capacity to incorporate and, hence, solubilize cholesterol. Excess cholesterol
crystallizes out, a process that is readily detected both by ESR spin labeling using 3-doxyl-5a-cholestane as a probe for
cholesterol and synchrotron x-ray scattering. Both methods yield entirely consistent results. The crystallization of cholesterol
from mixed bile salt micelles is indicated by the appearance of a magnetically dilute powder spectrum that is readily detected
by visual inspection of the ESR spectra. Both the absence of Heissenberg spin exchange and the observation of a magnetically
dilute powder spectrum provide evidence for the spin label co-crystallizing with cholesterol. In mixed bile salt micelles containing
egg phosphatidylcholine, the solubility of cholesterol is increased as detected by both methods. With increasing content of
phosphatidylcholine and increasing mole ratio cholesterol/phosphatidylcholine, the anisotropy of motion of the spin probe
increases. The spin label 3-doxyl-5a-cholestane is a useful substitute for cholesterol provided that it is used in dilute mixtures
with excess cholesterol: the cholesterol/spin label mole ratio in these mixtures should be greater than 100. Despite the structural
similarity between the two compounds, there are still significant differences in their physico-chemical properties. These dif-
ferences come to the fore when cholesterol is totally replaced by the spin-label: 3-doxyl-5a-cholestane is significantly less soluble
in bile salt and mixed bile salt micelles than cholesterol and, in contrast with cholesterol, it interacts only very weakly, if at all,
with phosphatidylcholine. The potential of the ESR method for detecting cholesterol crystal growth in human bile is discussed.
INTRODUCTION
Mixed bile salt micelles as well as phospholipid bilayers as
vesicles have been demonstrated to act as cholesterol carriers
in human bile (Small, 1967; Carey and Small, 1978; Mazer
et al., 1980; Somjen and Gilat, 1983; Somjen et al., 1986).
The main cholesterol carriers in unsaturated human bile are
small, spheroidal or disk-shaped mixed micelles consisting
of bile salt, phospholipid, and cholesterol plus simple mi-
celles consisting mainly of bile salt, which may contain cho-
lesterol (Hjelm et al., 1988; Walter et al., 1991). The solu-
bility of cholesterol in bile and the crystallization of excess
cholesterol from bile are two important properties intimately
related to the pathogenesis of cholesterol gallstones. Here we
use as a model system dispersions of mixed bile salts con-
taining cholesterol and egg PC spin-labeled with 3-doxyl-
5a-cholestane and test whether the crystallization of cho-
lesterol from these dispersions can be detected by ESR
spectroscopy. As a second independent method, x-ray dif-
fraction was applied to detect the crystallization of choles-
terol from model bile systems. Synchrotron radiation was
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used to enhance the sensitivity of the diffraction measure-
ment. Similar results were obtained with the two methods.
ESR spin labeling using 3-doxyl-5a-cholestane as a choles-
terol analog is a new and convenient method to detect crystal
formation of cholesterol in model systems. The method
might lend itself to application in human bile.
MATERIALS AND METHODS
Cholesterol (Sigma Chemical Co., St. Louis, MO) and Na+-taurocholate
(Sigma) were twice recrystallized from hot ethanol and ethanol and ether
(Pope, 1967), respectively. Egg phosphatidylcholine (PC) (Sigma) and spin-
labeled cholestane, 4,4'-dimethylspiro[5a-cholestane-3,2'-oxazolidine]-N-
oxyl (3-doxyl-5a-cholestane) (Aldrich, Steinheim, Germany) were used
without further purification. All lipids used in this study were pure by thin
layer chromatography standard. The lipids were dissolved in CHCIlCH30H
(2:1 v/v) in the proportions given in Table 1, dried at room temperature,
lyophilized overnight, and kept under argon until used. Unless stated oth-
erwise, lipid dispersions for ESR and x-ray scattering were prepared by
suspending the dried lipids in 50 mM Tris-HCI, pH 8.0, 150mM NaCl, and
incubating the suspension at 55°C for 1 h. Lipid suspensions were kept at
room temperature before the measurement, which was carried out within
less than 24 h. In the first series of experiments, 3-doxyl-5a-cholestane was
admixed to cholesterol so that the final cholesterol/spin label mole ratio was
100; in the second series of experiments, cholesterol was totally replaced
by 3-doxyl-5a-cholestane. All lipid dispersions were checked routinely for
the presence of cholesterol crystals by polarized light microscopy.
ESR spectra were recorded with a temperature-controlled Varian X-band
spectrometer (Model E-104A) operated in the continuous wave mode at 9.2
GHz (3280 G). Spin-labeled lipid dispersions (20-50 ,ul) were filled into
100-,lI glass capillaries (- 1mm internal diameter) with a Hamilton syringe,
and the capillaries were flame-sealed and immediately inserted into the ESR
cavity. ESR spectra were recorded at room temperature using an incident
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microwave power of less than 20 mW, 100 kHz field modulation, 1 G
modulation amplitude, 100 or 200 G field sweep, and a sweep rate of 12.5
G/min. The spin label concentration of lipid dispersions containing
cholesterol/3-doxyl-5a-cholestane (mole ratio 100:1) varied between 10 and
30 ,uM, whereas in lipid dispersions devoid of cholesterol the concentration
of 3-doxyl-5a-cholestane ranged from 10 to 30 mM. The temperature of the
sample was monitored with a thermocouple before and after recording the
ESR spectra and was maintained to within ±0.50.
Small angle x-ray scattering of the model bile systems was performed
on the storage ring DORIS using a double-focusing monochromator-mirror
camera (Koch and Bordas, 1983) installed at the X33 station of HASYLAB
(EMBL Outstation, DESY, Hamburg, Germany). All measurements were
made at A = 0.15 nm. Diffraction patterns from 100-,ul samples were re-
corded at 23 + 1°C with exposure times of 5 min. Before the evaluation,
background scattering caused by the buffer was subtracted from the dif-
fraction pattern. Further details of the data acquisition and evaluation sys-
tems can be found elsewhere (Boulin et al., 1986). Data are presented as
scattered intensity I vs. s, where s = 2 sin 0/A.
Auxiliary methods
Polarized light microscopy was used routinely to monitor the crystallization
of cholesterol or spin-labeled cholestane from bile salt dispersions. Freeze-
fracture electron microscopy was used as a second routine method to show
that the particles present in pure and mixed bile salt dispersions are pre-
dominantly small micelles.
RESULTS
ESR spin labeling
A representative ESR spectrum of bile salt micelles labeled
with a small amount of 3-doxyl-5a-cholestane is shown in
Fig. 1 A. The spectral shape is characteristic of fast, but
anisotropic, motion with a maximum hyperfine splitting of
2A1 = 38 G. Similar ESR spectra were obtained with
cholate, taurocholate, and glycocholate micelles (all as the
sodium salt; data not shown) (cf. Stevens, 1977). The average
maximum hyperfine splitting measured with 3-doxyl-5a-
cholestane in various bile salt micelles was 2AI = 37.5 +
0.7 G. Fig. 1 B shows the ESR spectrum of a dispersion of
sodium taurocholate containing cholesterol/3-doxyl-5a-
cholestane (mole ratio 100:1, cf. sample 1, Table 11). This
is a composite ESR spectrum. The lineshape of the main
spectral component is very similar to the ESR spectrum
shown in Fig. 1 A and is characteristic of spin-labeled cho-
lestane present in bile salt micelles. The second minor com-
ponent is an immobilized ESR spectrum characterized by a
maximum hyperfine splitting 2Amax = 71 G (see arrows in
Fig. 1 B). This value of the maximum hyperfine splitting,
which actually exceeds the Azz component of the hyperfine
splitting tensor, indicates that we are dealing with a mag-
netically dilute powder spectrum. ESR spectra were recorded
of bile salt micelles to which increasing quantities of
cholesterol/3-doxyl-5a-cholestane (mole ratio 100:1) were
added. With increasing cholesterol/3-doxyl-5a-cholestane
content, the relative intensity of the immobilized component
with 2Amax = 71 G increased proportionally (data not shown).
However, no contribution from Heissenberg spin exchange
was detected in the ESR spectra of this series of samples,
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FIGURE 1 (A) ESR spectrum of sodium deoxycholate micelles spin-
labeled with 3-doxyl-5a-cholestane. The bile salt (50 mM, -2.1%) con-
taining the spin label at a mole ratio of 250:1 was dispersed in 10mM sodium
phosphate buffer pH 7.3, 140 mM NaCl, 25 mM EDTA. The maximum
hyperfine splitting 2A, was derived directly from the ESR spectrum as
indicated. Sweep width = 100 G. The chemical structure of 3-doxyl-Sa-
cholestane is shown as an inset. (B) ESR spectrum of a lipid dispersion
(sample 1 ofTable 1) containing 100mM sodium taurocholate (-5.6%) and
20 mM cholesterol/3-doxyl-5a-cholestane (mole ratio 100) in 50 mM Tris-
HCI buffer pH 8.0, 150mM NaCl. The maximum hyperfine splittings of the
two component spectra were derived from this spectrum as indicated. Sweep
width = 200 G.
consisting of bile salt micelles and increasing quantities of
cholesterol/3-doxyl-5a-cholestane (mole ratio 100:1, cf. Fig.
1 B). Computer simulations lend support to this interpreta-
tion. The experimental spectrum of Fig. 1 B can be simulated
by the sum of two component spectra characterized by maxi-
mum hyperfine splittings of 2AI = 38 G and 2Amax = 72 G,
and the simulations confirm the conclusion that there is no
contribution from spin exchange (data not shown). The im-
mobilized spectra are probably indicative of slow motional
contributions to the lineshape and the effective hyperfine
splittings. However, rigorous simulations of these spectra
and a detailed lineshape analysis are not required for the
interpretation of these spectra given here.
The kinetics of the crystallization of cholesterol from
mixed bile salt micelles can be derived from the time course
of the appearance of the magnetically dilute powder spec-
trum with 2Amax = 72 G. The increase in signal intensity of
this spectrum with time parallels the crystal growth as moni-
tored by polarized light microscopy (data not shown). For
instance, sample 1 (Table 1) containing 3-doxyl-5a-
cholestane (cholesterol/spin label mole ratio = 100) at time
0 gave rise to an ESR spectrum identical to that of Fig. 1 A.
Between 1 and 2 h after dispersion of this sample, the second
spectral component characterized by 2Amax = 72 G was first
detected and, eventually, the composite ESR spectrum
shown in Fig. 1 B was obtained. Between 24 and 48 h, the
signal intensity of the second spectral component reached its
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TABLE 1 Composition and maximum hyperfine splittings of mixed bile salt micelles
Maximum hyperfine
splittings (2 Amaxt)
Sodium Total lipid Cholesterol/ Mobile Immobile
Sample Cholesterol Egg PC taurocholate conc. Cholesterol egg PC component component
No. (mM) (mM) (mM) (g/dl) (mol %) (mole ratio) CSI* (G) (G)
1 20 100 5.8 16.7 00 n.d. 37.8 71.0
2 10 100 5.4 9.1 00 n.d. 37.5 72.5
3 10 15 100 6.5 8.0 0.67 180 43.1 + 0.8 n.d.
4 10 20 100 6.8 7.7 0.50 146 43.5 + 1.0 n.d.
5 10 30 100 7.6 7.1 0.33 106 42.9 + 0.3
6 10 40 100 8.4 6.7 0.25 87 42.1 + 0.3
7 10 50 100 9.2 6.3 0.20 77 41.8 + 0.6
8 20 50 100 9.6 11.8 0.40 143 43.5 + 0.4
9 30 50 100 9.9 16.7 0.60 201 43.5 ± 1.0
10 10 50 150 11.6 4.8 0.20 63 41.0 + 0.3
*CSI, cholesterol saturation index derived according to Carey (1978).
tFor ESR measurements, all samples contained cholesterol/3-doxyl-5a-cholestane (mole ratio 100:1). For composite ESR spectra consisting of two com-
ponent spectra, two maximum hyperfine splittings are given. The mobile component refers to the ESR spectrum of 3-doxyl-5a-cholestane present in bile
salt micelles, and the immobilized component is due to the spin label present in cholesterol crystals.
n.d., not determined.
maximum (data not shown). The determination of the crystal
growth by this ESR method is subject to a large error due to
growing crystals sedimenting in the ESR tube. The kinetics
of the crystal growth of cholesterol from different bile salt
dispersions and the methodology involved in this measure-
ment will be the subject of a separate publication.
In the second series of ESR experiments, mixed bile salt
micelles of the same lipid composition as in Table 1 were
used except that cholesterol was replaced by spin-labeled
cholestane. A representative ESR spectrum of this series is
shown in Fig. 2 (corresponding to sample 1, Table 1). This
ESR spectrum is also composed of two spectral components;
one spectrum is very similar to that shown in Fig. 1 A and
is characteristic of the spin label present in bile salt micelles.
As seen in Fig. 2, this spectrum is apparently superimposed
on a spin exchange spectrum. Consistent with x-ray diffrac-
tion experiments discussed below (cf. Figs. 5, 6 C, and 7 C),
the ESR spectra of all samples of this series showed a sig-
nificant contribution from spin exchange, indicating that a
lOG
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FIGURE 2 ESR spectrum of sodium taurocholate micelles (100 mM,
-5.6%) containing 20mM 3-doxyl-5a-cholestane dispersed in 50mM Tris-
HCI buffer, pH 8.0, 150 mM NaCl. The experimental spectrum (A, )
can be computer-fitted by the sum of a spin exchange spectrum (-- -) and
an anisotropic spectrum (B) characteristic of the spin label in bile salt mixed
micelles with a maximum hyperfine splitting of 2AI = 38 G. Spectral
baseline (.. ).
sizable proportion of the spin label crystallized out under
these conditions. This was true for bile salt micelles both in
the absence and presence of PC (cf. Fig. 4) and is taken as
evidence that the solubility of 3-doxyl-5a-cholestane in pure
and mixed bile salt micelles is rather limited.
ESR spectra of sodium taurocholate micelles containing a
fixed quantity of cholesterol/3-doxyl-5a-cholestane (mole
ratio 100:1) and increasing amounts of PC are depicted in
Fig. 3 (samples 2-5, Table 1). Inspection of the ESR spectra
of Fig. 3 reveals two effects of increasing the PC content in
mixed bile salt micelles: (1) the intensity of the immobilized
spectrum with 2Amax = 72 G (see arrows) decreased with
increasing PC content; at PC concentrations >15 mM, this
spectral component is barely detectable; (2) the incorporation
of PC into bile salt micelles caused an increase in the maxi-
mum hyperfine splitting 2A1 from about 38 G, characteristic
of 3-doxyl-5a-cholestane present in pure bile salt micelles to
40-40.5 G, characteristic of the spin label present in PC bi-
layers. As shown in Table 1, the value of 2A1 increased
approximately linearly with cholesterol content, leveling off
at2A =43.5G.
In Fig. 4, ESR spectra are presented of mixed bile salt
micelles of composition analogous to samples 7-9 of Table
1, except that in these dispersions cholesterol was totally
replaced by spin-labeled cholestane. As discussed for Fig. 2,
composite ESR spectra are obtained under these conditions
consisting of a spin exchange spectrum and a three-line spec-
trum characteristic of spin-labeled cholestane present in bile
salt micelles. The intensity of the spin exchange spectrum
obtained by spectral decomposition as described for Fig. 2
increased linearly with the spin label content (data not
shown).
In the series of micellar dispersions corresponding to
samples 3-7 of Table 1 in which cholesterol was totally
replaced by spin-labeled cholestane, we found that the
spin exchange contribution in the ESR spectra only
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FIGURE 3 ESR spectra ofmixed bile salt micelles. All samples contained
100 mM (-5.6%) sodium taurocholate, 10 mM cholesterol/3-doxyl-5a-
cholestane (cholesterol/spin label mole ratio 100), and increasing quantities
of egg PC except for A, which contained no egg PC (sample 2 of Table 1).
The mixed bile salt dispersions contained 15 mM egg PC (B) (sample 3 of
Table 1), 20 mM egg PC (C) (sample 4 of Table 1), 30 mM egg PC (D)
(sample S of Table 1). Sweep width = 200 G. Arrows indicate the maximum
hyperfine splitting 2Amax of the immobilized spectrum. (-- - -) Spectral
baseline. Vertical solid lines indicate the maximum hyperfine splitting 2A,
characteristic of the spin label present in bile salt micelles.
slightly decreased going from sample 3 to 7 (data not
shown). This result indicated that increasing contents of
PC in mixed bile salt micelles have only a marginal effect
on the solubility of the cholestane spin label in these
micelles. As far as the interaction with PC is concerned,
spin-labeled cholestane therefore behaved significantly
differently from cholesterol.
Small angle x-ray scattering
In Fig. 5, x-ray diffraction patterns of sodium taurocholate
dispersions containing cholesterol/3-doxyl-5a-cholestane
(mole ratio 100:1, pattern A) and pure spin-labeled choles-
tane (pattern B) are compared. The 34.1-A diffraction peak
can be attributed to cholesterol crystals (Craven, 1976). In
contrast, in bile salt dispersions containing spin-labeled cho-
lestane without cholesterol, the measured diffraction peak
was at 19.5 A. The presence of PC in the taurocholate dis-
FIGURE 4 ESR spectra of mixed bile salt micelles containing 100 mM
(-5.6%) sodium taurocholate, 50 mM egg PC, and increasing quantities of
3-doxyl-Sa-cholestane; the concentration of spin label was 10 mM (A), 20
mM (B), and 30 mM (C). Bile salt dispersions were made in 50 mM Tris-
HCI buffer, pH 8.0, 150mM NaCl. Sweep width = 200 G. The spectral gain
used was 1.6 X 103, 1.25 X 103, and 1.0 X 103 for spectraA-C, respectively.
persions renders the cholesterol soluble in mixed bile salt
dispersions, as seen in Fig. 6, A and B. In these bile salt
dispersions, the cholesterol and taurocholate concentrations
remained constant, whereas egg PC was varied from 15 to
-4-.
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FIGURE 5 X-ray scattering profiles are presented after background sub-
traction and normalization to a constant beam intensity. Two model bile salt
systems are shown. (A) 150 mM (-8.3%) sodium taurocholate, 10 mM
cholesterol/3-doxyl-5a-cholestane (mole ratio 100:1). (B) The same bile
salt dispersion as above except that cholesterol was replaced by spin-labeled
cholestane. Both dispersions were made in 50 mM Tris-HCl buffer, pH 8.0,
150 mM NaCl as described in Materials and Methods. The first-order dif-
fraction peaks due to cholesterol crystals and crystals of 3-doxyl-Sa-
cholestane are marked with Ch and SLC, respectively.
I I I I I I
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A comparison was made of mixed bile salt dispersions
containing constant concentrations of egg PC (50 mM) and
sodium taurocholate (100 mM) and increasing concentra-
tions of cholesterol in the absence and presence of spin-
labeled cholestane. First-order diffraction peaks were ob-
served at 74.7 and 77.1 A (Fig. 7 A) and at 79.7 and 77.1 A
(Fig. 7 B), indicative of lamellar stacking. In this figure, a
shoulder centered at a larger value of s than that of the main
diffraction peak can be seen (cf. dashed arrow). In the dis-
persions containing 1 mol% 3-doxyl-5a-cholestane, this
shoulder is already observed at a lower cholesterol content
(20 mM) (cf. dashed arrow, Fig. 7 B).
The dispersions composed of pure cholestane spin label
showed strong diffraction peaks at 19.5 A due to the crystalli-
zation of spin-labeled cholestane (see arrow in Fig. 7 C). The
intensities of these peaks appear to be proportional to the amount
of 3-doxyl-5a-cholestane in the different dispersions.
Auxiliary measurements
The following measurements were carried out routinely for
the purpose of aiding in the interpretation of the ESR and
0.3 0.4 0.5
s (nm )
FIGURE 6 X-ray scattering profiles of mixed bile salt dispersions in 50
mM Tris-HCl buffer, pH 8.0,150mM NaCl. (A) Samples containing 10mM
cholesterol, 100 mM (-5.6%) sodium taurocholate, and 15-50 mM PC
(samples 3-7 of Table 1, bottom to top); (B) Samples 3-7 of Table 1 except
that each sample contained 1 mol% 3-doxyl-5a-cholestane (bottom to top).
(C) Samples 3-7 ofTable 1 except that cholesterol was replaced by 3-doxyl-
Sa-cholestane. The lamellar diffraction peaks are marked by arrows in B.
The diffraction peaks due to crystalline 3-doxyl-5a-cholestane in C are
marked by an arrow. The numbers on the right of the scattering profiles refer
to the egg PC concentration (in mM).
50 mM (samples 3-7 of Table 1). As seen in Fig. 6, A and
B, no cholesterol crystals could be detected. Lamellar stack-
ing is indicated in x-ray scattering by the appearance of rela-
tively sharp diffraction peaks at submultiples of about 80 A
(Somjen et al., 1991). No lamellar stacking was detected in
mixed bile salt dispersions containing pure cholesterol (Fig.
6 A). In samples of the same composition but containing 1
mol% 3-doxyl-5a-cholestane, lamellar stacking was detect-
able (see arrows in Fig. 6 B). For mixed bile salt micelles
containing 15, 20, 30, and 40 mM egg PC, the shoulders or
peaks marked by arrows correspond to 71.7, 73.0, 76.3, and
78.1 A, respectively. A shift of the maxima and minima of
the scattering profiles was observed. When the dispersions
were prepared with spin-labeled cholestane instead of cho-
lesterol, sharp diffraction peaks at 19.5 A were observed (see
arrow in Fig. 6 C). This is evidence for the crystallization
of the 3-doxyl-5a-cholestane molecules. However, no la-
mellar stacking was observed in these dispersions. The
minima and maxima of the scattering profiles were shifted
from their original positions of the cholesterol-containing
samples, indicating a change in the micellar size.
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
s (nm 1 )
FIGURE 7 X-ray scattering profiles of mixed bile salt dispersions in 50
mM Tris-HCl buffer, pH 8.0, 150 mM NaCl. (A) Samples 7-9 of Table 1
(bottom to top). (B) Samples 7-9 of Table 1 except that each sample con-
tained 3-doxyl-Sa-cholestane at a cholesterol/3-doxyl-5a-cholestane mole
ratio of 100 (bottom to top). (C) Samples 7-9 of Table 1 except that all
cholesterol was replaced by 3-doxyl-Sa-cholestane. The lamellar diffraction
peaks are indicated by arrows; shoulders of these diffraction peaks are
marked by dashed arrows (A and B). The arrow in C marks the diffraction
peaks due to the crystallization of 3-doxyl-Sa-cholestane.
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x-ray scattering experiments. The crystallization of choles-
terol from saturated pure and mixed bile salt micelles was
monitored routinely by polarized light microscopy. The crys-
tallization of cholesterol or spin-labeled cholestane from bile
salt micelles detected by either ESR spin labeling or x-ray
diffraction was confirmed by this routine method.
DISCUSSION
Here we used the spin-labeled cholestane 3-doxyl-5a-
cholestane (see inset of Fig. 1 A) as a probe of cholesterol
behavior in bile salt micelles. The same spin label was used
by Stevens (1977) to probe glycocholate-mixed micelles
containing egg PC and/or cholesterol. This author obtained
ESR spectra very similar to that shown in Fig. 1 A. However,
he treated the spectra as pseudo-isotropic and interpreted
them in terms of rotational correlation times.
For the interpretation of the ESR spectra, we assume that
Brownian tumbling of the whole micelle does not contribute
significantly to the averaging of the hyperfine splitting ten-
sor. Hence, the observed ESR lineshape reflects primarily the
molecular motion of the spin label. This assumption is rea-
sonable considering the average dimensions of the mixed bile
salt micelles. The composite ESR spectrum shown in Fig. 1
B arises from the limited solubility of cholesterol and spin-
labeled cholestane in pure bile salt micelles (Small et al.,
1966a, b). The observation of an immobilized spectral com-
ponent with an average value for the maximum hyperfine
splitting of 2Ama = 72 ± 1 G is interpreted to indicate that
excess cholesterol crystallizes out giving rise to the immo-
bilized spectrum (see arrows in Fig. 1 B). This immobilized
spectrum is a magnetically dilute powder spectrum, indicat-
ing that the cholestane spin-label co-crystallizes with cho-
lesterol. Phase separation or demixing of cholesterol and the
cholestane spin label in the crystal would give rise to a spin
exchange spectrum. Because there was no detectable con-
tribution from spin exchange to the ESR spectrum shown in
Fig. 1 B, phase separation or demixing can be ruled out. If
all cholesterol is replaced by the cholestane spin label, a
Heissenberg spin exchange spectrum is observed instead of
the magnetically dilute powder spectrum (cf. Figs. 1 B and
2). The observation of spin exchange indicates that 3-doxyl-
5a-cholestane, like cholesterol, has a limited solubility in
bile salt micelles and excess spin label crystallizes out. In
summarizing the ESR evidence, we conclude that the crys-
tallization of cholesterol from mixed bile salt micelles is
indicated by the appearance of a magnetically dilute, rigid
limit powder spectrum; in contrast, the crystallization of
3-doxyl-Sa-cholestane from mixed bile salt micelles, in
which all cholesterol is replaced by the spin label, is indicated
by spin exchange.
We have observed reproducibly that in magnetically di-
lute, rigid limit powder spectra of 3-doxyl-5a-cholestane the
value of the maximum hyperfine splitting Ama = 35-36 G
exceeds significantly the Azz component of the hyperfine
splitting tensor. The value published for A in the early lit-
erature is Azz = 32 G (Smith, 1971; Gaffney, 1976; Hsia et
al., 1970; Smith and Butler, 1976). The Am. value we ob-
serve is more in line with the Azz value of 34.5 G used by
Freed and his collaborators in the simulation of ESR spectra
of 3-doxyl-Sa-cholestane present in oriented multilayers of
1,2-dipalmitoyl-sn-phosphatidylcholine (Kar et al., 1985).
The high Am. value cannot be due to an error in the instru-
mental field scan, which was calibrated with Fremy's salt:
measured and nominal values of the hyperfine splitting
agreed within 2%. The high Ama values are very likely due
to hydrogen bonding of the nitroxide group to water. Hy-
drogen bonding or, more generally, a more polar environ-
ment of this group was shown to increase the unpaired spin
density on the N-atom of the nitroxide group, leading to an
increase in the hyperfine splitting (Griffith et al., 1974; John-
son, 1981; Marsh, 1981; Kar et al., 1985).
Our interpretation of the ESR results is supported by evi-
dence from x-ray diffraction (Fig. 5). Dispersions of 150 mM
bile salt micelles containing 10 mM spin-labeled cholestane
or 10 mM cholesterol/3-doxyl-5a-cholestane (mole ratio,
100:1) yielded sharp diffraction peaks superimposed on the
x-ray scattering profile arising from bile salt micelles. The
diffraction peak corresponding to 34.1 A observed with bile
salt dispersions containing cholesterol is consistent with the
single-crystal structure of cholesterol monohydrate (Craven,
1976). The cholesterol monohydrate crystallizes in the form
of bilayers with a repeat distance d(ool) = 33.9 A. For the
dispersion, in which cholesterol was totally replaced by the
spin label, a sharp diffraction peak corresponding to 19.5 A
was observed (Fig. 5 B). The single-crystal structure of the
cholestane spin label is not available. The repeat distance of
19.5 A is significantly smaller than that of the cholesterol
monohydrate crystal. The reason for this discrepancy is un-
known. One possible explanation is that in the crystal struc-
ture of 3-doxyl-5a-cholestane the molecules pack in an in-
terdigitated monolayer. In such a structure, neighboring
molecules are packed head-to-tail with the steroid nuclei
forming the hydrophobic interior and polar nitroxide groups
forming the surface layers on either side of the hydrophobic
region.
Although exact values of the solubilities of cholesterol and
3-doxyl-Sa-cholestane in sodium taurocholate micelles were
not determined here, an estimate of the upper limit of these
values can be derived. Both ESR spin labeling and X-ray
diffraction show that less than -6 mol% cholesterol is
soluble in taurocholate micelles. This value is even smaller
for 3-doxyl-Sa-cholestane. From the spin exchange contri-
bution to the ESR spectra shown in Fig. 4, a value of about
5 mM (=3.2 mol%) is derived for the solubility of 3-doxyl-
Sa-cholestane in taurocholate-PC mixed micelles. At spin
label concentrations in excess of 5 mM (=3.2 mol%), spin
exchange is observed with mixed taurocholate micelles of
composition shown in Fig. 4. At a spin label concentration
of 6.3 mol% (cf. ESR spectrumA of Fig. 4) the spin exchange
is clearly detectable. The limited solubility of cholesterol in
bile salt micelles is in agreement with the ternary phase dia-
gram of bile salt-cholesterol-water as well as the quaternary
phase diagram of bile salt-PC-cholesterol-water, according
Somjen et al. 2347
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to which only limited quantities of cholesterol are accom-
modated in pure and mixed bile salt micelles (Small et al.,
1966a, b; Bourges et al., 1967; Carey and Small, 1978).
Stevens (1977) observed discontinuities in the plot of cor-
relation times versus cholesterol content of mixed glyco-
cholate micelles. These discontinuities apparently coincide
with the phase boundary or solubility limit of cholesterol in
the quaternary phase diagram bile salt-PC-cholesterol-water
(Bourges et al., 1967) and also with the appearance of mag-
netically dilute, rigid limit powder spectra in mixed tauro-
cholate micelles of comparable compositions as described
here.
Fig. 3 together with Figs. 5 to 7 provide evidence that the
presence of PC increases the capacity of bile salt micelles to
incorporate cholesterol (Wilson and Rudel, 1994). No im-
mobilized component due to the crystallization of cholesterol
was detectable in the ESR spectra of bile salt micelles con-
taining more than 15 mM (12 mol%) egg PC keeping the
concentrations of bile salt (100 mM) and cholesterol/3-
doxyl-5a-cholestane (10 mM) constant (cf. Fig. 3). Consis-
tent with this finding, the x-ray diffraction patterns of these
samples are devoid of sharp diffraction peaks characteristic
of crystalline cholesterol (cf. Figs. 6, A and B and 7, A and
B). In contrast, in bile salt dispersions in which cholesterol
was totally replaced by the cholestane spin label, sharp dif-
fraction peaks characteristic of crystalline 3-doxyl-5a-
cholestane are observed (cf. Figs. 6 C and 7 C). These results
clearly show that the presence of egg PC in mixed bile salt
micelles increases the solubility of cholesterol but not of
spin-labeled cholestane in these micelles. This finding is con-
sistent with results obtained by Stevens (1977).
The presence of PC in mixed bile salt micelles increases
the maximum hyperfine splitting and, hence, the anisotropy
of motion (Table 1). There is an initial linear relationship
between the maximum hyperfine splitting 2AI and the
cholesterol/PC mole ratio (cf. data in Table 1). This is in-
terpreted to be a manifestation of the interaction between
cholesterol and PC molecules. Cholesterol-PC interactions
have been studied extensively and are well documented in the
literature (see, e.g., Finean, 1990). In contrast, in mixed bile
salt micelles, in which cholesterol was totally replaced by
spin-labeled cholestane, an analogous interaction between
spin-labeled cholestane and PC was not detected. Upon add-
ing increasing quantities of PC to mixed bile salt micelles
(samples 3-7 ofTable 1, except that cholesterol was replaced
by spin-labeled cholestane), no significant reduction in the
intensity of the spin exchange spectrum was observed. At the
highest PC concentration (samples 6-10 of Table 1), the 2AI
values were 40-41 G, characteristic of the spin label present
in PC bilayers; all other mixed bile salt dispersions (samples
1-5 of Table 1 with cholesterol being replaced by spin-
labeled cholestane) gave ESR spectra with an average 2AI
value of 38 ± 0.8 G, characteristic of the spin label present
in bile salt micelles. These two lines of evidence that (1)
increasing quantities of PC in mixed bile salt micelles con-
taining a fixed amount of 3-doxyl-5a-cholestane have little
if any effect on the intensity of the spin exchange spectrum,
and (2) the presence of PC has no or little effect on the
maximum hyperfine splitting of the mobile spectral com-
ponent demonstrate that 3-doxyl-5a-cholestane behaves
quite differently from cholesterol regarding its interaction
with PC. There is no or only a very weak interaction with PC.
One explanation for this is that 3-doxyl-Sa-cholestane lacks
an H-bond donor function and, unlike cholesterol, this mol-
ecule cannot form a hydrogen bond to the carbonyl group of
fatty acyl chains of PC or membrane phospholipids.
Both ESR and x-ray diffraction data indicate consistently
that the physico-chemical properties of spin-labeled choles-
tane differ from those of cholesterol. Both methods clearly
show that spin-labeled cholestane is less soluble than cho-
lesterol in mixed bile salt micelles containing PC. Further,
both methods provide evidence that there is only a very weak,
if any, interaction between spin-labeled cholestane and PC.
Differences in the surface properties of cholesterol and
3-doxyl-Sa-cholestane have been reported by Cadenhead et
al. (1972, 1975). Despite these obvious differences in the
physico-chemical properties of cholesterol and 3-doxyl-5a-
cholestane, the data presented still demonstrate the utility of
the spin label when it is used in dilute mixtures with cho-
lesterol at cholesterol/spin label mole ratios >100. Under
these conditions, the label appears to probe the behavior of
cholesterol satisfactorily; moreover it co-crystallizes with
cholesterol.
In dispersions of mixed micelles with a relatively high
cholesterol content (>7 mol%, Table 1), sharp lamellar dif-
fraction peaks are observed superimposed on the x-ray scat-
tering pattern arising from bile salt micelles (Figs. 6 B and
7, A and B). The sharp diffraction lines are indicative of a
periodic structure that was identified previously using small
angle x-ray diffraction (Somjen et al., 1991). Lamellar dif-
fraction peaks were observed by x-ray diffraction with mixed
bile salt dispersions 3-6, 8, and 9 of Table I that contained
between 6.7 and 16.7 mol% cholesterol. This result suggests
that the occurrence of lamellar stacking requires a threshold
concentration of cholesterol in the mixed bile salt micelle.
The principle governing the stacking was discussed previ-
ously (Somjen et al., 1991).
In conclusion, we find that the two independent methods,
ESR spin labeling and synchrotron x-ray scattering, used
here to characterize the behavior of mixed bile salt/
cholesterol/PC micelles give consistent results. 3-doxyl-Sa-
cholestane is a reasonably good substitute for cholesterol
provided that it is used together with excess cholesterol at
cholesterol/3-doxyl-5a-cholestane mole ratios >100. Al-
though there are clear differences in the physico-chemical
properties of cholesterol and 3-doxyl-5a-cholestane, the spin
label was found to co-crystallize with cholesterol. The data
presented here clearly show that the crystallization of cho-
lesterol from bile salt micelles is readily detected by ESR
using 3-doxyl-5a-cholestane. When the spin label is used in
magnetically dilute dispersions, e.g., as cholesterol/3-doxyl-
Sca-cholestane mixtures (mole ratio, 100:1) crystallization of
cholesterol manifests itself in the appearance of a magneti-
cally dilute powder pattern. If cholesterol is totally replaced
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by spin-labeled cholestane, the crystallization of the spin
label is indicated by the appearance of a spin exchange spec-
trum. ESR spin labeling and x-ray diffraction show that bile
salt micelles can accommodate about 5 mol% cholesterol and
3 mol% 3-doxyl-5a-cholestane. Excess cholesterol and
3-doxyl-5a-cholestane crystallize out. ESR spin labeling as
a relatively inexpensive as well as sensitive method may lend
itself as a routine method for detecting the crystal growth of
cholesterol in human bile. Native bile would have to be
equilibrated with sufficient spin-labeled cholestane so that
the crystallization of cholesterol can be detected. Work is
currently in progress in our laboratory (H. Hauser) to test the
potential of the ESR method in this respect.
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